Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Azelaic Acid 18%/Niacinamide 4%/Brimonidine Tartrate 0.4% Topical Cream is a potent blend of active ingredients, dispensed in a pump mechanism for convenient and controlled application. This formulation is designed to effectively treat various skin conditions such as Rosacea, Acne, Melasma, Hyperpigmentation, and Seborrheic Dermatitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized topical cream formulation of Azelaic Acid 18%/Niacinamide 4%/Brimonidine Tartrate 0.4%.
Azelaic Acid, a naturally occurring dicarboxylic acid, has demonstrated its efficacy in reducing inflammation, decreasing the production of sebum, and inhibiting the growth of bacteria on the skin. Niacinamide, a derivative of Vitamin B3, is known for its anti-inflammatory properties, its ability to enhance skin barrier function, and its role in mitigating hyperpigmentation. Brimonidine Tartrate, an alpha-2 agonist, is instrumental in reducing redness and inflammation.
This compounded formulation is dispensed in a pump mechanism, a semisolid preparation designed for convenient and controlled application on the skin. This allows for localized treatment or absorption of the active ingredients, ensuring maximum effectiveness.
It works by reducing inflammation, decreasing the production of sebum, inhibiting the growth of bacteria on the skin, improving skin barrier function, and reducing hyperpigmentation.
If you have any queries about this formulation or how it can assist in treating your skin condition, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you find the most suitable treatment option tailored to your individual needs.
Azelaic Acid 18%/Niacinamide 4%/Brimonidine Tartrate 0.4% Topical Cream is a compounded formulation designed for the treatment of mild to moderate rosacea, acne vulgaris, and melasma. This semisolid preparation is dispensed in a pump mechanism, ensuring a convenient and controlled application on the skin for localized treatment or absorption of active ingredients.
The formulation contains Azelaic Acid 18%, an anti-inflammatory agent that helps reduce the redness and swelling associated with rosacea. It also aids in reducing the number of acne lesions and lightening melasma. Niacinamide 4%, an antioxidant in the formulation, helps to reduce inflammation and the appearance of hyperpigmentation. Brimonidine Tartrate 0.4%, a vasoconstrictor, assists in reducing the redness associated with rosacea.
Patients should be advised to avoid contact with the eyes, lips, and mucous membranes when using this formulation. Sun exposure should also be avoided, and the use of a sunscreen with an SPF of 30 or higher is recommended. A thin layer of the cream should be applied to the affected area twice daily. However, it is important to note that this formulation may cause skin irritation, redness, or dryness. If these side effects occur, patients should be advised to reduce the frequency of application or discontinue use.
Patients with a known hypersensitivity to any of the components should not use this formulation. If you have any questions about the use of Azelaic Acid 18%/Niacinamide 4%/Brimonidine Tartrate 0.4% Topical Cream, please reach out for further information.
Azelaic Acid 18%/Niacinamide 4%/Brimonidine Tartrate 0.4% Topical Cream is a compounded formulation designed to address various skin conditions such as acne, rosacea, and melasma. This unique blend of active ingredients works synergistically to provide comprehensive skin care.
Azelaic acid, constituting 18% of the formulation, is a potent antibacterial and anti-inflammatory agent. It works by reducing the number of acne-causing bacteria on the skin and mitigating inflammation. This helps in managing acne and reducing the associated redness and swelling.
Niacinamide, a form of vitamin B3, makes up 4% of the formulation. It is known for its ability to reduce the appearance of hyperpigmentation and improve skin tone. Regular use of niacinamide can lead to a more even and radiant complexion.
Brimonidine tartrate, at a concentration of 0.4%, is a vasoconstrictor. It helps reduce redness and flushing associated with rosacea by constricting the blood vessels in the skin, thereby reducing blood flow to the area.
This topical cream is dispensed in a pump mechanism, which allows for convenient and controlled application. It is designed for localized treatment, ensuring that the active ingredients are absorbed where they are needed most. The cream should be applied to the affected area once or twice daily, or as directed by your healthcare provider. It is crucial to avoid contact with the eyes, mouth, and other mucous membranes when applying the cream.
If you have any questions about using Azelaic Acid 18%/Niacinamide 4%/Brimonidine Tartrate 0.4% Topical Cream, please do not hesitate to reach out. We are here to assist you in finding the most suitable treatment for your skin condition.
This compounded formulation of Azelaic Acid 18%/Niacinamide 4%/Brimonidine Tartrate 0.4% Topical Cream is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. It is primarily used for localized treatment or absorption of active ingredients. This formulation is versatile and can be used to treat a variety of skin conditions such as actinic keratosis, post-inflammatory hyperpigmentation, and skin laxity.
Additionally, this formulation is beneficial in reducing the appearance of dark spots and discoloration. It has anti-inflammatory properties that help reduce inflammation and redness. For optimal results, it is recommended to use this formulation twice daily, once in the morning and once in the evening.
It is important to note that while this formulation is designed to address a variety of skin concerns, results may vary from person to person. Always consult with a healthcare professional before starting any new skincare regimen. If you have any questions about how to use this formulation, please reach out to a healthcare professional or a pharmacist.
This is a specially formulated topical cream that combines Azelaic Acid, Niacinamide, and Brimonidine Tartrate. It is designed to be applied to the skin for localized treatment.
This cream is dispensed in a pump mechanism, which allows for convenient and controlled application on the skin.
The active ingredients in this cream are Azelaic Acid (18%), Niacinamide (4%), and Brimonidine Tartrate (0.4%).
Azelaic Acid is used to treat mild to moderate acne. It works by reducing the growth of bacteria in the pores of the skin and decreasing the production of keratin, a natural substance that can lead to the development of acne.
Niacinamide, also known as Vitamin B3, is known for its anti-inflammatory properties. It can help reduce redness and swelling associated with acne or other skin conditions.
Brimonidine Tartrate is used to reduce redness or rosacea on the face. It works by narrowing the blood vessels in the skin, which reduces redness and flushing.
This cream should be applied to the affected area of the skin as directed by your healthcare provider. The pump mechanism allows for controlled application.
Generally, this cream can be used for all skin types. However, it's always best to consult with your healthcare provider or a dermatologist to determine if this formulation is suitable for your specific skin condition and type.
As with any medication, there can be potential side effects. These may include dryness, peeling, or a burning sensation at the application site. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Before combining this cream with other skincare products, it's best to consult with your healthcare provider or a dermatologist. They can provide guidance based on the specific ingredients and your skin's needs.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
